---
title: "Xinyuren: Wang Jiayan plans to reduce his holdings by no more than 0.07% of the company's shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236948029.md"
description: "Xinyuren announced that director Wang Jiayan plans to reduce his holdings by no more than 68,443 shares through centralized bidding from May 20, 2025, to August 19, 2025, accounting for 0.07% of the company's total share capital. Wang Jiayan currently holds 273,800 shares, accounting for 0.28% of the company's total share capital"
datetime: "2025-04-22T10:55:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236948029.md)
  - [en](https://longbridge.com/en/news/236948029.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236948029.md)
generator: "portal-rs"
---

# Xinyuren: Wang Jiayan plans to reduce his holdings by no more than 0.07% of the company's shares

Xinyuren announced that director Wang Jiayan plans to reduce his holdings by no more than 68,443 shares through centralized bidding from May 20, 2025, to August 19, 2025, accounting for 0.07% of the company's total share capital. Wang Jiayan currently holds 273,800 shares, accounting for 0.28% of the company's total share capital

### Related Stocks

- [688573.CN](https://longbridge.com/en/quote/688573.CN.md)

## Related News & Research

- [Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2](https://longbridge.com/en/news/298452346.md)
- [AERLIN closes seed round with eFUEL GROUP, IBB Ventures among new shareholders](https://longbridge.com/en/news/298426941.md)
- [SynAct Pharma bolsters resomelagon data as it readies Phase 3 and weighs strategic deals](https://longbridge.com/en/news/298195637.md)
- [EWG: Double-digit revenue growth and digital platform adoption drive robust margins and returns](https://longbridge.com/en/news/298417346.md)
- [Trump Threatens To Ban Bombardier Aircraft Sales](https://longbridge.com/en/news/298367480.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**